Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
9 hasil
Binding of galectin-3 by low molecular weight pectin
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Binding of galectin-3 by low molecular weight pectin
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Binding of galectin-3 by low molecular weight pectin
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to improvement of mammalian, including human, biological conditions impacted by, or mediated by, galectin-3. Galectin-3 is a member of the lectin family, of which at least fourteen (14) mammalian galectins have been
Feed compositions for preventing and treating inflammatory diseases
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is the U.S. National Phase under 35 U.S.C. .sctn. 371 of International Application No. PCT/EP2016/066351, filed Jul. 8, 2016, designating the U.S., and published in English as WO 2017/009257 A2 on Jan. 19, 2017, which claims priority to European Patent Application No. 15176285.3,
Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FEDERALLY SPONSORED RESEARCH
Not Applicable
SEQUENCE LISTING OR PROGRAM
Not Applicable
BACKGROUND OF THE INVENTION
1. Field of Invention
The present application generally relates to nutrition, in particular an ultra-high fiber supplement, the making of the supplement, and its use in weight loss,
Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins.
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FEDERALLY SPONSORED RESEARCH
Not Applicable
SEQUENCE LISTING OR PROGRAM
Not Applicable
BACKGROUND OF THE INVENTION
1. Field of Invention
The present application generally relates to nutrition, in particular an ultra-high fiber supplement, the making of the supplement, and its use in weight loss,
Reduction of galectin-3 levels by plasmapheresis
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
PRIORITY DATA AND INCORPORATION BY REFERENCE
This application claims benefit of priority to U.S. Provisional Patent Application No. 61/568,210 filed Dec. 8, 2011 which is incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention pertains to
Galectin-3 plasmapheresis therapy
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate
Galectin-3 plasmapheresis therapy
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Field of the Invention
This invention pertains to treatment of disease and biological conditions mediated at least in part by one or more galectins. Galectins are a family of lectins (sugar binding proteins) that are characterized by having at least one carbohydrate
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
